标题
Complex roles of the old drug aspirin in cancer chemoprevention and therapy
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-06-01
DOI
10.1002/med.21514
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Distinct Chemopreventive Effects of Aspirin in Diffuse and Intestinal-Type Gastric Cancer
- (2018) Ryota Niikura et al. Cancer Prevention Research
- ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma
- (2018) Maria Paula Ceballos Mancini et al. CURRENT MEDICINAL CHEMISTRY
- Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies
- (2018) Natalia Khalaf et al. GASTROENTEROLOGY
- Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study
- (2018) Ka Shing Cheung et al. JNCI-Journal of the National Cancer Institute
- Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults
- (2018) In Cheol Hwang et al. Scientific Reports
- Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin, and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea
- (2018) Minyong Kang et al. Cancer Research and Treatment
- Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study
- (2018) Ka Shing Cheung et al. JNCI-Journal of the National Cancer Institute
- The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It
- (2018) Heather Armstrong et al. Cancers
- COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss
- (2017) Simon J. Crabb et al. EUROPEAN JOURNAL OF CANCER
- Physiopathology and genetics in aspirin-exacerbated respiratory disease
- (2017) Gandhi F. Pavón-Romero et al. EXPERIMENTAL LUNG RESEARCH
- Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention
- (2017) Giovanni Brandi et al. HEPATOLOGY
- Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
- (2017) Minjong Lee et al. HEPATOLOGY
- Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
- (2017) Rakesh Dachineni et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival
- (2017) Xinwei Hua et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status
- (2017) Tsuyoshi Hamada et al. JOURNAL OF CLINICAL ONCOLOGY
- World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
- (2017) Hidekazu Suzuki et al. JOURNAL OF GASTROENTEROLOGY
- Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
- (2017) Linxin Li et al. LANCET
- Effects of aspirin on small-cell lung cancer mortality and metastatic presentation
- (2017) Paul Maddison LUNG CANCER
- Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and Developability Issues
- (2017) Yueqin Zheng et al. MEDICINAL RESEARCH REVIEWS
- The inflammatory microenvironment and microbiome in prostate cancer development
- (2017) Karen S. Sfanos et al. Nature Reviews Urology
- Thromboxane Formation Assay to Identify High On-Treatment Platelet Reactivity to Aspirin
- (2017) Annemarie Mohring et al. PHARMACOLOGY
- The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis
- (2017) Martine A. Frouws et al. PLoS One
- Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
- (2017) Debashree Basudhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of Multiplate and VerifyNow platelet function tests in predicting clinical outcome in patients with acute coronary syndromes
- (2017) Peter D Larsen et al. THROMBOSIS RESEARCH
- Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
- (2017) Hongping Xia et al. Cell Death & Disease
- Role of Aspirin in Breast Cancer Survival
- (2017) Wendy Y. Chen et al. Current Oncology Reports
- Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study
- (2017) Livia Archibugi et al. Scientific Reports
- Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection
- (2016) Pei-Chang Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug
- (2016) Poulami Khan et al. BMC CANCER
- Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients
- (2016) J. Shiao et al. BREAST CANCER RESEARCH AND TREATMENT
- Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
- (2016) Sanja B. Turturro et al. BREAST CANCER RESEARCH AND TREATMENT
- The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives
- (2016) Demetrios Moris et al. Breast Care
- CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
- (2016) Holger Bronger et al. BRITISH JOURNAL OF CANCER
- Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- (2016) Marie C. Bradley et al. CANCER
- Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women’s Health Study
- (2016) Lisa E. Vaughan et al. CANCER CAUSES & CONTROL
- Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case–control study
- (2016) Pik Fang Kho et al. CANCER CAUSES & CONTROL
- Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study
- (2016) Charlotte Skriver et al. CANCER CAUSES & CONTROL
- Exploring Differences in the Aspirin–Colorectal Cancer Association by Sex and Race/Ethnicity: The Multiethnic Cohort Study
- (2016) Song-Yi Park et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Aspirin Use and Reduced Risk of Pancreatic Cancer
- (2016) Harvey A. Risch et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1
- (2016) Lenard M. Lichtenberger et al. Cancer Prevention Research
- Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice
- (2016) G. Mattheolabakis et al. Cancer Prevention Research
- Targeting Inflammation in Cancer Prevention and Therapy
- (2016) J. Todoric et al. Cancer Prevention Research
- Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB–IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells
- (2016) Shilpi Saha et al. CANCER RESEARCH
- Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
- (2016) Davide Capodanno et al. CIRCULATION
- ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
- (2016) Christopher Coyle et al. Contemporary Clinical Trials
- The role of aspirin in colorectal cancer chemoprevention
- (2016) Gurpreet Singh Ranger CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms
- (2016) Giovanni Brandi et al. DIGESTIVE AND LIVER DISEASE
- Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1
- (2016) Francesca Rauzi et al. FASEB JOURNAL
- Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes
- (2016) Yin Cao et al. GASTROENTEROLOGY
- Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study
- (2016) Xiaozhou Fan et al. GUT
- Aspirin use and the risk of cholangiocarcinoma
- (2016) Jonggi Choi et al. HEPATOLOGY
- Cholangiocarcinoma risk factors and the potential role of aspirin
- (2016) Fabio Bagante et al. HEPATOLOGY
- A brief review on the mechanisms of aspirin resistance
- (2016) Gang Du et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study
- (2016) Simer J. Bains et al. JOURNAL OF CLINICAL ONCOLOGY
- Does aspirin use reduce the risk for cancer?
- (2016) Usman Iqbal et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
- (2016) Theodore M. Brasky et al. JNCI-Journal of the National Cancer Institute
- Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety
- (2016) Catarina Pereira-Leite et al. MEDICINAL RESEARCH REVIEWS
- Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer
- (2016) Yan Huang et al. MOLECULAR CANCER THERAPEUTICS
- Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer
- (2016) Koji Matsuo et al. OBSTETRICS AND GYNECOLOGY
- AMPK promotes tolerance to Ras pathway inhibition by activating autophagy
- (2016) S Sanduja et al. ONCOGENE
- Evaluation of platelet function using PFA-100® in patients treated with Acetylsalicylic acid and qualified for Trauma and Orthopedic surgery procedures
- (2016) J. Kurak et al. PLATELETS
- Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial
- (2016) Thea Veitonmäki et al. PLoS One
- Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling
- (2016) C. Rutherford et al. Science Signaling
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis
- (2016) Parambir S Dulai et al. BMJ-British Medical Journal
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis
- (2016) Parambir S Dulai et al. BMJ-British Medical Journal
- The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis
- (2016) Pengfei Kong et al. Journal of Cancer
- Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
- (2016) Theodore M. Brasky et al. JNCI-Journal of the National Cancer Institute
- Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling
- (2016) C. Rutherford et al. Science Signaling
- Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
- (2016) Yin Cao et al. JAMA Oncology
- NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications
- (2015) Ravinder Kodela et al. BIOCHEMICAL PHARMACOLOGY
- Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer
- (2015) Sangmi Kim et al. BMC CANCER
- A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties
- (2015) Irida Kastrati et al. BMC CANCER
- Low-dose aspirin and survival from lung cancer: a population-based cohort study
- (2015) Úna C. Mc Menamin et al. BMC CANCER
- Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
- (2015) Angelo Restivo et al. BRITISH JOURNAL OF CANCER
- Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence
- (2015) Mary Kay Barton CA-A CANCER JOURNAL FOR CLINICIANS
- Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial
- (2015) D. B. Liesenfeld et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator
- (2015) Brandon Faubert et al. CANCER LETTERS
- NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
- (2015) J. L. Petrick et al. Cancer Prevention Research
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR
- (2015) Yancun Yin et al. CELL RESEARCH
- Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF- B Pathway
- (2015) D. Liao et al. CLINICAL CANCER RESEARCH
- Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial
- (2015) Hossein Esmaeilzadeh et al. CLINICAL IMMUNOLOGY
- Epidemiology of Low Dose Aspirin Damage in the Lower Gastrointestinal Tract
- (2015) Carlos Sostres et al. CURRENT PHARMACEUTICAL DESIGN
- Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use
- (2015) Katsunori Iijima et al. CURRENT PHARMACEUTICAL DESIGN
- Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease
- (2015) Masakazu Yashiro DIGESTIVE DISEASES AND SCIENCES
- The risk of prostate cancer for men on aspirin, statin or antidiabetic medications
- (2015) Tobias Nordström et al. EUROPEAN JOURNAL OF CANCER
- Aspirin-exacerbated respiratory disease: characteristics and management strategies
- (2015) Ronald A Simon et al. Expert Review of Clinical Immunology
- Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice
- (2015) Dingzhi Wang et al. GASTROENTEROLOGY
- Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants
- (2015) Hongmei Nan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Novel Resveratrol-Based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity
- (2015) Yingdong Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Use of Aspirin and the Risk of Mortality in Patients with Prostate Cancer
- (2015) Jonathan Assayag et al. JOURNAL OF UROLOGY
- Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention
- (2015) R. Dachineni et al. MOLECULAR CANCER RESEARCH
- Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53
- (2015) Guoqiang Ai et al. TUMOR BIOLOGY
- Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries
- (2015) Chen Mo WORLD JOURNAL OF GASTROENTEROLOGY
- Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy
- (2015) Wen Yue et al. Scientific Reports
- Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies
- (2015) Yan-Peng Zhang et al. Scientific Reports
- NOSH-Aspirin Inhibits Colon Cancer Cell Growth: Effects Of Positional Isomerism
- (2015) Federica Vannini et al. Redox Biology
- Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance
- (2015) Haitao Li et al. EBioMedicine
- Inhibition of Pancreatic Intraepithelial Neoplasia Progression to Carcinoma by Nitric Oxide-Releasing Aspirin in p48Cre/+-LSL-KrasG12D/+ Mice
- (2015) Chinthalapally V. Rao et al. NEOPLASIA
- Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice
- (2014) Liam J Murray et al. BREAST CANCER RESEARCH
- Case-Control Study of Aspirin Use and Risk of Pancreatic Cancer
- (2014) S. A. Streicher et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pancreatic Cancer, Inflammation, and Microbiome
- (2014) Constantinos P. Zambirinis et al. CANCER JOURNAL
- Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study
- (2014) A. C. Vidal et al. CLINICAL CANCER RESEARCH
- Aspirin May Prevent Cholangiocarcinoma: A Case–Control Study from the United Kingdom
- (2014) N. E. Burr et al. DIGESTIVE DISEASES AND SCIENCES
- Association analysis ofFABP1gene polymorphisms with aspirin-exacerbated respiratory disease in asthma
- (2014) Hun Soo Chang et al. EXPERIMENTAL LUNG RESEARCH
- Genetic Polymorphisms of Platelet Receptors in Patients with Acute Myocardial Infarction and Resistance to Antiplatelet Therapy
- (2014) Jana Ulehlova et al. Genetic Testing and Molecular Biomarkers
- Platelet Glycoprotein IIIa Gene Polymorphism (Leu33Pro) and Aspirin Resistance in a Very Elderly Chinese Population
- (2014) Bei-Yun Wang et al. Genetic Testing and Molecular Biomarkers
- Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis
- (2014) Peiwei Li et al. GUT
- Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
- (2014) Monika Świerczyńska-Krępa et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Daily Aspirin Use and Prostate Cancer–Specific Mortality in a Large Cohort of Men with Nonmetastatic Prostate Cancer
- (2014) Eric J. Jacobs et al. JOURNAL OF CLINICAL ONCOLOGY
- Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
- (2014) Antonina V. Kurtova et al. NATURE
- Hydroxybenzoic acid isomers and the cardiovascular system
- (2014) Bernhard HJ Juurlink et al. Nutrition Journal
- Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect
- (2014) Liqun Huang et al. PLoS One
- Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies
- (2014) Jeanne Tie et al. Targeted Oncology
- Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial
- (2013) Nancy R. Cook et al. ANNALS OF INTERNAL MEDICINE
- Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin
- (2013) J Etulain et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Novel Combinatorial Nanotechnology-Based Oral Chemopreventive Regimen Demonstrates Significant Suppression of Pancreatic Cancer Neoplastic Lesions
- (2013) B. K. Grandhi et al. Cancer Prevention Research
- Autophagy and human diseases
- (2013) Peidu Jiang et al. CELL RESEARCH
- Initiation of Aspirin Therapy Modulates Angiogenic Protein Levels in Women with Breast Cancer Receiving Tamoxifen Therapy
- (2013) Chris E. Holmes et al. CTS-Clinical and Translational Science
- A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice
- (2013) Bincy Philip et al. GASTROENTEROLOGY
- Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
- (2013) Reiko Nishihara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type I and II Endometrial Cancers: Have They Different Risk Factors?
- (2013) Veronica Wendy Setiawan et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin Use is Associated with Lower Prostate Cancer Risk in Male Carriers of BRCA Mutations
- (2013) Matthew Cossack et al. Journal of Genetic Counseling
- Aspirin Use, 8q24 Single Nucleotide Polymorphism rs6983267, and Colorectal Cancer According to CTNNB1 Alterations
- (2013) Hongmei Nan et al. JNCI-Journal of the National Cancer Institute
- Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression
- (2013) Mitali Chattopadhyay et al. LEUKEMIA RESEARCH
- Phosphorylation of BRAF by AMPK Impairs BRAF-KSR1 Association and Cell Proliferation
- (2013) Che-Hung Shen et al. MOLECULAR CELL
- Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: A randomized multicenter study
- (2013) Kamil Karolczak et al. PHARMACOLOGICAL RESEARCH
- Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model
- (2013) Yi-Rang Na et al. PLoS One
- Novel Single Nucleotide Polymorphism Markers for Low Dose Aspirin-Associated Small Bowel Bleeding
- (2013) Akiko Shiotani et al. PLoS One
- Evading apoptosis in cancer
- (2013) Kaleigh Fernald et al. TRENDS IN CELL BIOLOGY
- NOSH–aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model
- (2012) Mitali Chattopadhyay et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glucose–aspirin: Synthesis and in vitro anti-cancer activity studies
- (2012) James N. Jacob et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
- (2012) F M Shebl et al. BRITISH JOURNAL OF CANCER
- Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort
- (2012) P. K. Dhillon et al. Cancer Prevention Research
- Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level
- (2012) Thea Veitonmäki et al. EUROPEAN JOURNAL OF CANCER
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
- (2012) Farhat V.N. Din et al. GASTROENTEROLOGY
- Use of Aspirin, Other Nonsteroidal Anti-Inflammatory Drugs, and Acetaminophen and Postmenopausal Breast Cancer Incidence
- (2012) Xuehong Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
- (2012) Vikrant V. Sahasrabuddhe et al. JNCI-Journal of the National Cancer Institute
- Cancer prevention by targeting angiogenesis
- (2012) Adriana Albini et al. Nature Reviews Clinical Oncology
- Aspirin and urologic cancer risk: an update
- (2012) Cristina Bosetti et al. Nature Reviews Urology
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- H(2)S-Releasing Aspirin Protects against Aspirin-Induced Gastric Injury via Reducing Oxidative Stress
- (2012) Lei Liu et al. PLoS One
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors
- (2012) I. K. Sur et al. SCIENCE
- The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
- (2012) S. A. Hawley et al. SCIENCE
- NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals
- (2012) Ravinder Kodela et al. ACS Medicinal Chemistry Letters
- Metformin Accelerates the Growth of BRAF V600E -Driven Melanoma by Upregulating VEGF-A
- (2012) Matthew J. Martin et al. Cancer Discovery
- Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo
- (2011) Mitali Chattopadhyay et al. BIOCHEMICAL PHARMACOLOGY
- Curcumin: A component of the golden spice, targets multiple angiogenic pathways
- (2011) Vivek R. Yadav et al. CANCER BIOLOGY & THERAPY
- Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
- (2011) A. T. Chan et al. Cancer Prevention Research
- Chemotherapeutic Properties of Phospho-Nonsteroidal Anti-Inflammatory Drugs, a New Class of Anticancer Compounds
- (2011) L. Huang et al. CANCER RESEARCH
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- Aspirin
- (2011) Valentin Fuster et al. CIRCULATION
- Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action
- (2011) Jennie L. Williams et al. EXPERIMENTAL CELL RESEARCH
- Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model
- (2011) MOHAMMAD AKBAR HOSSAIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics
- (2010) H. S. Cheong et al. ALLERGY
- NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation
- (2010) Mitali Chattopadhyay et al. CANCER LETTERS
- Gentisic Acid, a Compound Associated with Plant Defense and a Metabolite of Aspirin, Heads a New Class ofin VivoFibroblast Growth Factor Inhibitors
- (2010) Israel S. Fernández et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aspirin-induced peptic ulcer and genetic polymorphisms
- (2010) Akiko Shiotani et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Modulation of the Biological Properties of Aspirin by Formation of a Bioorganometallic Derivative
- (2009) Ingo Ott et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs
- (2009) Kumar V.S. Nemmani et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
- (2009) C C Abnet et al. BRITISH JOURNAL OF CANCER
- Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden
- (2009) V. T. T. Nguyen et al. JOURNAL OF VIRAL HEPATITIS
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
- (2009) Mark M Pomerantz et al. NATURE GENETICS
- The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling
- (2009) Sari Tuupanen et al. NATURE GENETICS
- Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling
- (2008) Hui Zhou et al. CANCER LETTERS
- NO-donating aspirin inhibits the activation of NF-κB in human cancer cell lines and Min mice
- (2008) Jennie L. Williams et al. CARCINOGENESIS
- A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin
- (2008) Elena Piazuelo et al. CLINICAL THERAPEUTICS
- Alkyne hexacarbonyl dicobalt complexes in medicinal chemistry and drug development
- (2008) Ingo Ott et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21
- (2008) Albert Tenesa et al. NATURE GENETICS
- Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome
- (2008) John Burn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets
- (2006) Catriona M Turnbull et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now